23,663 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Lilly Acquisitions

Lilly has acquired 37 companies and its latest acquisition was Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program on Jan 2025

Unlock 34 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program

Jan 2025

Source »
$2.5B
-
Morphic Therapeutic, Inc.

Jul 2024

Source »
$3.2B
Morphic is a Massachusetts-based biopharmaceutical company that develops oral integrin therapies for the treatment of autoimmune, cardiovascular, and metabolic diseases.
Aparito

Jul 2024

Source »
undisclosed
Aparito is a Wales-based clinical trials platform that captures data through mobile apps, video assessments and wearable devices for drug development applications.
Radionetics Oncology, Inc.

Jul 2024

Source »
$140M
Radionetics Oncology is a California-based radiopharmaceutical company that discovers and develops novel therapeutics for the treatment of cancer.
POINT Biopharma Global, Inc.

Oct 2023

Source »
$1.4B
POINT is an Indiana-based radiopharmaceutical company that develops and commercializes radioligands for the treatment of cancer.

Frequently Asked Questions about Lilly

  1. What companies did Lilly acquire?

    Companies acquired by Lilly include , Morphic and Aparito

  2. How many acquisitions does Lilly have?

    Lilly has acquired 37 companies including , Morphic and Aparito.

  1. How many acquisitions did Lilly make in 2025?

    In 2025 Lilly acquired 1 companies including undefined.